The opioid crisis remains a national public health emergency, Acting Health and Human Services Secretary Eric Hargan declared Friday, renewing the administration’s October declaration effective Jan. 24. In November, the President’s Commission on Combating Drug Addiction and the Opioid Crisis released its final report with more than 50 recommendations to address the opioid epidemic. Among other recommendations, the report urged Congress and the administration to block grant federal funding for opioid- and substance-use-disorder-related activities to the states; grant waiver approvals for all 50 states to eliminate barriers to treatment caused by the Medicaid Institutions for Mental Diseases exclusion; better align patient privacy laws specific to addiction with the Health Insurance Portability and Accountability Act; mandate prescriber education to enhance prevention; expand access to medication-assisted treatment; combat illicit fentanyl; enhance data sharing among prescription drug monitoring programs; and enforce the Mental Health Parity and Addiction Equity Act.

Related News Articles

Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…